Home  >  Research  >  Labs  >  Cardiovascular Science and Diabetes Program  >  MOLECULAR ENDOCRINOLOGY AND PHARMACOLOGY

RESEARCH OVERVIEW

Endocrinology and Pharmacology are the study of how hormones and pharmaceuticals act in the body respectively. At the molecular and cellular level, the focus is upon the receptors in the cell membranes that bind the hormones and pharmaceuticals, transmitting or blocking specific signals into our cells. The laboratory’s work is currently focused primarily on developing better treatments for kidney disease, cardiovascular disease and cancer.

This group mainly studies the molecular function of G protein-coupled receptors (GPCRs) and their signalling pathways, but is also starting to expand into other target classes such as receptor tyrosine kinases (RTKs), because of their importance in cancer in particular (Ayoub et al., 2013; O’Brien et al., 2018), and the Receptor for Advanced Glycation End-Products (RAGE), especially because of its importance in cardiovascular disease (Pickering et al., 2019).

GPCRs are a family of over 800 different cell surface sensors in the human body. Their function is diverse and, among many more, includes the detection of light (vision) and odorants (smell), as well as the regulation of growth, metabolism, reproduction, immune responses etc. Key GPCRs also have important roles in cancer, such as the chemokine receptors (Watts et al., 2013). Not surprisingly, between a third and a half of all currently available pharmaceuticals modulate GPCR function to mitigate various diseases and conditions.

The major research focus of the group is the study of receptor complexes and their role in receptor function. Receptors interact with a variety of different proteins as well as other receptors, and it is important to understand how the resultant complexes work in terms of signalling and regulation. The aim is to use this knowledge to develop substantially improved pharmaceuticals with fewer side effects.

Professor Kevin Pfleger

Professor Kevin Pfleger

Molecular Endocrinology and Pharmacology

Read more

LATEST NEWS

UWA Research Awards – Special Commendation awarded to Perkins Researcher

Professor Pilar Blancafort, Group Leader of the Cancer Epigenetics laboratory and Head of the Cancer Program at the Harry Perkins Institute of Medical Research and The University of Western Australia’s Centre for Medical Research received a Special Commendation from the Judging Panel at the 2026 UWA Vice-Chancellor's Senior Research Award,…

Read More

Perkins researchers win big at the WA Innovators of the Year Awards

Prof Shirley Jansen (left), A/Prof Juliana Hamzah (middle), Atherid Therapeutics CEO Meghan Thomas (right) Last night Associate Professor Juliana Hamzah, Professor Shirley Jansen AM and Atherid Therapeutics were the recipients of the Community Benefit and Wellbeing Award at the Western Australia's Innovators of the Year event. Co-founders of CAD SPECTRAL…

Read More

Funding to improve cardiovascular health outcomes

Researchers developing innovative technology for early heart disease detection have received more than $298,000 from the Heart Foundation’s 2026 research funding program. They have been awarded Vanguard Grants to test the feasibility of innovative, non-invasive technology with the aim to improve cardiovascular health. Professor Girish Dwivedi, head of the Cardiovascular…

Read More

I'M LOOKING FOR

RESEARCH PROJECTS

TEAM MEMBERS

PUBLICATIONS